Emerson (EMR) PT Raised to $140 at Deutsche Bank

Deutsche Bank analyst Nicole DeBlase raised the price target on Emerson (NYSE: EMR) to $140.00 (from $136.00) while maintaining a Buy rating.

The analyst comments "EMR stock traded up nearly 7% today, and while the modest 3% 4Q24 core adj. segment EBITA beat and FY25 guidance positioned 1% above consensus ($5.85- 6.05 range vs. $5.88 consensus) was certainly helpful, we think the bulk of the outperformance can be attributed to the strategic announcements made in conjunction with 4Q results. To this point, EMR announced three key strategic actions that will 'complete' its portfolio transformation to an Industrial Technology Leader Delivering Advanced Automation Solutions: 1) Proposed the acquisition of the remaining 43% of AZPN shares for $240/share in cash, 2) Commenced a strategic review of the Safety & Productivity segment, and 3) Committed to repurchase $2bn of stock in FY25, with $1bn in 1Q25."

You May Also Be Interested In

• JPMorgan Downgrades KFin Technologies Ltd (KFINTECH:IN) to Neutral
• JPMorgan Starts Nippon Life India Asset Management Ltd (NAM:IN) at Overweight
• Bernstein SocGen Group Reiterates Outperform Rating on Zydus Lifesciences (ZYDUSLIF:IN)